Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 8.34% on an annualized basis producing an average annual return of 16.94%. Currently, Vertex Pharmaceuticals has a market capitalization of $96.01 billion.
Buying $1000 In VRTX: If an investor had bought $1000 of VRTX stock 20 years ago, it would be worth $22,680.80 today based on a price of $374.46 for VRTX at the time of writing.
Vertex Pharmaceuticals’s Performance Over Last 20 Years
Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Great Job Benzinga Insights & the Team @ Benzinga – Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals Source link for sharing this story.